by Mayo Clinic Credit: CC0 Public Domain Mayo Clinic researchers studied the outcomes of 483 high-risk patients treated for COVID-19 with a five-day oral regimen of nirmatrelvir and ritonavir, together marketed as Paxlovid. Only a handful developed COVID-19 rebound symptoms, and the researchers say more studies are needed to determine why. Overall, the treatment benefited...
Tag: <span>Paxlovid</span>
Post
Telehealth aims to crack open Paxlovid’s prescription bottleneck
By Katie Palmer May 10, 2022 Reprints Boxes of Pfizer’s Paxlovid antiviral medication. After months of shortages, pharmacies across the U.S. are being stocked with drugs to treat Covid-19. Now, the primary bottleneck has become getting a prescription. BLOOMBERG PHOTO BY KOBI WOLF After months of shortages, pharmacies across the United States are being stocked...
- 1
- 2